AAPL 229.98 0.7535% MSFT 429.03 1.0481% NVDA 137.71 3.0995% GOOGL 196.0 1.6018% GOOG 197.55 1.6151% AMZN 225.94 2.3928% META 612.77 0.2405% AVGO 237.44 3.5003% TSLA 426.5 3.0641% TSM 211.5 -1.5317% LLY 725.72 -4.208% V 319.62 0.747% JPM 259.16 1.9232% UNH 509.76 -0.1626% NVO 78.69 -5.2727% WMT 91.94 0.701% LVMUY 142.08 -1.4497% XOM 112.32 0.8983% LVMHF 710.0 -0.9487% MA 524.7 0.2982%
Last update at 2025-01-17T21:25:00Z
Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand
Wed 15 Jan 25, 05:23 PMQuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
Tue 14 Jan 25, 04:49 PMReturns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
Tue 14 Jan 25, 12:00 PMAngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
Thu 09 Jan 25, 02:48 PMAbbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?
Wed 08 Jan 25, 03:35 PMInsiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
Wed 08 Jan 25, 01:00 PMIs Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?
Mon 06 Jan 25, 02:38 PMAbbott Laboratories (NYSE:ABT) Could Easily Take On More Debt
Sat 04 Jan 25, 12:00 PMJim Cramer’s Take on Abbott Laboratories (ABT): Bold Predictions for the Future
Wed 01 Jan 25, 05:45 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 8306.00M | 8211.00M | 4968.00M | 4077.00M | 2873.00M |
Minority interest | - | - | 219.00M | 213.00M | 198.00M |
Net income | 6933.00M | 7071.00M | 4495.00M | 3687.00M | 2368.00M |
Selling general administrative | 11012.00M | 11324.00M | 9696.00M | 9765.00M | 9744.00M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 24511.00M | 24538.00M | 19605.00M | 18673.00M | 17872.00M |
Reconciled depreciation | 2013.00M | 2047.00M | 3327.00M | 3014.00M | 3278.00M |
Ebit | 8362.00M | 8425.00M | 5357.00M | 4532.00M | 3789.00M |
Ebitda | 10696.00M | 10749.00M | 7592.00M | 6659.00M | 5967.00M |
Depreciation and amortization | 2334.00M | 2324.00M | 2235.00M | 2127.00M | 2178.00M |
Non operating income net other | 502.00M | 319.00M | 157.00M | 215.00M | 49.00M |
Operating income | 8362.00M | 8425.00M | 5357.00M | 4532.00M | 3650.00M |
Other operating expenses | 35291.00M | 34650.00M | 29251.00M | 27372.00M | 26928.00M |
Interest expense | 375.00M | 490.00M | 500.00M | 576.00M | 721.00M |
Tax provision | 1373.00M | 1140.00M | 497.00M | 390.00M | 539.00M |
Interest income | 377.00M | 491.00M | 492.00M | 94.00M | 105.00M |
Net interest income | -375.00000M | -490.00000M | -500.00000M | -576.00000M | -721.00000M |
Extraordinary items | - | 0.00000M | 24.00M | 86.00M | -96.00000M |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 1373.00M | 1140.00M | 497.00M | 390.00M | 539.00M |
Total revenue | 43653.00M | 43075.00M | 34608.00M | 31904.00M | 30578.00M |
Total operating expenses | 16149.00M | 16113.00M | 14248.00M | 14141.00M | 14222.00M |
Cost of revenue | 19142.00M | 18537.00M | 15003.00M | 13231.00M | 12706.00M |
Total other income expense net | -56.00000M | -214.00000M | -389.00000M | -455.00000M | -56.00000M |
Discontinued operations | - | - | 24.00M | 24.00M | 34.00M |
Net income from continuing ops | 6933.00M | 7071.00M | 4471.00M | 3687.00M | 2334.00M |
Net income applicable to common shares | 6933.00M | 7071.00M | 4495.00M | 3687.00M | 2353.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 74438.00M | 75196.00M | 72548.00M | 67887.00M | 67173.00M |
Intangible assets | 10454.00M | 12739.00M | 14784.00M | 17025.00M | 18942.00M |
Earning assets | - | - | - | - | - |
Other current assets | 2663.00M | 2346.00M | 1867.00M | 1786.00M | 1568.00M |
Total liab | 37533.00M | 39172.00M | 39545.00M | 36586.00M | 36451.00M |
Total stockholder equity | 36686.00M | 35802.00M | 32784.00M | 31088.00M | 30524.00M |